The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug ...

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...

The facility, which will produce cell therapies used to treat cancer and auto immune diseases, creates 150 jobs for highly ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...

AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said on Tuesday, ...

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to ...

The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...

AstraZeneca CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...

The drugmaker posted increased core earnings per share and sales for the first quarter, but also said it could face a fine of ...